← Back
$BOLT All transactions

Bolt Biotherapeutics, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$686

Shares

125

Price

$5

Filed

Oct 24

Why this score? (7/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Quinn William P.

Title

President, CEO and CFO

CIK

0001724190

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-06

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,188

Footnotes

Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c) | The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. | The restricted stock units subject to the award will vest in full on September 15, 2026, assuming continued employment through such date.

Filing Info

Accession No.

0001193125-25-250332

Form Type

4

Issuer CIK

0001641281

Quinn William P.'s History

Date Ticker Type Value
2026-01-28 BOLT A $0
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A

Other Insiders at BOLT (90d)

Insider Bought Sold Last
Quinn William P.
President, CEO and CFO
$576 2026-01-28
Nemec Sarah
Senior VP, Finance and PAO
$576 2026-01-28
Yonehiro Grant
Chief Operating Officer
2026-01-28